ACE PHARMA
ActiveACE PHARMA has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €222k and a net result of €2k. Equity remains stable across the filed fiscal years (±2.2% per year). Its solvency ranks better than 85% of 18016 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Checked score
Score 2025
86
/ 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability4▼-5
Solvency100=
Growth52=
Stability100
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €19k at 30 days acceptable
Liquidity ample (current ratio 3.76 against 4.06 in 2024), and 23.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
76.6%
Return on assets
0.6%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
25 d early
2024
28 d early
2023
133 d early
2022
28 d early
2021
37 d early
2020
54 d early
2019
23 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
14-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€2k▼ 54.0%
2024 · €4k
2018: €41k
2019: €19k
2020: €16k
2021: €24k
2022: €26k
2023: €27k
2024: €4k
2018 → 2025
Working capital
€187k▼ 0.9%
2024 · €189k
2018: €126k
2019: €132k
2020: €151k
2021: €184k
2022: €187k
2023: €183k
2024: €189k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€234k-€229k▼ 1.9%€216k▼ 5.8%€220k▲ 1.8%€222k▲ 0.8%
Operating result€35k-€39k▲ 10.1%€36k▼ 7.1%€7k▼ 81.7%€4k▼ 33.8%
Net result€24k-€26k▲ 9.7%€27k▲ 1.0%€4k▼ 85.0%€2k▼ 54.0%
Result per fiscal year
Operating resultNet result
The operating result has fallen three years in a row; 2025 is 34% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €290k
Fixed assets
€34k▲ 11.7%
Current assets
€255k▲ 1.7%
Equity and liabilities €290k
Equity
€222k▲ 0.8%
Debt
€68k▲ 9.8%
The debt ratio rises from 21.9% to 23.4%: debt grows faster than equity.
Key figures and ratios
EBITDA
€9k▼
2024 · €11k
Cash flow
€6k▼
2024 · €8k
Solvency
76.6%▼
2024 · 78.1%
Current ratio
3.76▼
2024 · 4.06
Quick ratio
2.30▼
2024 · 2.37
Debt / equity
0.31▲
2024 · 0.28
ROE
0.8%▼
2024 · 1.8%
ROA
0.6%▼
2024 · 1.4%
Interest coverage
4.31▼
2024 · 7.30
Debt
€68k▲
2024 · €62k
Debt ≤ 1 year
€68k▲
2024 · €62k
Income taxes
€763▼
2024 · €2k
Staff costs
€28k▲
2024 · €6k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€282k€290k▲
Fixed assets21/28€31k€34k▲
Tangible fixed assets22/27€31k€34k▲
Land and buildings22€26k€23k▼
Plant, machinery and equipment23€2k€4k▲
Furniture and vehicles24€3k€1k▼
Assets under construction and advance payments27-€6k
Current assets29/58€251k€255k▲
Stocks and contracts in progress3€105k€99k▼
Stocks30/36€105k€99k▼
Amounts receivable within one year40/41€57k€62k▲
Trade receivables40€49k€58k▲
Other amounts receivable41€9k€4k▼
Cash at bank and in hand54/58€87k€92k▲
Deferred charges and accrued income490/1€2k€2k▲
Equity and liabilities
Total equity and liabilities10/49€282k€290k▲
Equity10/15€220k€222k▲
Contributions10/11€12k€12k=
Reserves13€93k€84k▼
Distributable reserves133€93k€84k▼
Profit (loss) carried forward14€115k€125k▲
Amounts payable17/49€62k€68k▲
Amounts payable within one year42/48€62k€68k▲
Trade debts44€60k€64k▲
Suppliers440/4€60k€64k▲
Taxes, remuneration and social security45€2k€4k▲
Taxes450/3€2k€755▼
Remuneration and social security454/9€417€3k▲
Other amounts payable47/48€118€118=
Income statement
Code20242025
Remuneration, social security and pensions62€6k€28k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€4k▲
Other operating charges640/8€6k€13k▲
Gross operating margin9900€23k€50k▲
Operating profit (loss)9901€7k€4k▼
Financial income75/76B€553€274▼
Recurring financial income75€553€274▼
Financial charges65/66B€1k€2k▲
Recurring financial charges65€1k€2k▲
Profit (loss) for the period before taxes9903€6k€3k▼
Income taxes67/77€2k€763▼
Profit (loss) for the period9904€4k€2k▼
Profit (loss) for the period to be appropriated9905€4k€2k▼
Appropriation of the result
Profit (loss) to be appropriated9906€115k€116k▲
Profit (loss) brought forward from the previous period14P€111k€115k▲
Transfer from equity791/2-€9k
Social balance
Average headcount (FTE)90870.1-
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
06-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €2k ▼54%
Net result drops to €2k, the lowest in the series.
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
20-03
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
03-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
24-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
07-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Equity above €200kEq €210k ▲7.9%
3 profitable years in a row build equity to €210k.
08-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
04-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
15-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
13-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 directors, no change since 2024
CELOR Management
CurrentManaging director · since 15-04-2024
ESSENTIAL Management
CurrentDirector · since 15-04-2024
15-04-2024
CELOR Management: Appointed as Managing director
15-04-2024
ESSENTIAL Management: Appointed as Director
15-04-2024
Pascale MAQUOI: Resigned as Director
15-04-2024
Céline Orban: Appointed as Représentante permanente de celor management
15-04-2024
Erwin Gillissen: Appointed as Représentant permanent de essential management
22-12-2023
Pascale MAQUOI: Appointed as Director
Location & real-estate footprint
Registered office, Fexhe-le-Haut-Clocher · 1 establishment unit since 1989
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Grand'Route 2894347 Fexhe-le-Haut-ClocherGround area
422 m²
Building footprint
205 m²
Volume, LiDAR
811 m³
Parcel 64025B0211/00V000, Wallonia · tallest building 9.5 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Grand'Route 289, 4347 Fexhe-le-Haut-Clocher
since 19892.041.817.930
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 64025B0211/00V000 | Wallonia | 422 m² | 1 · 205 m² | 9.4 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteFexhe-le-Haut-Clocher2.041.817.930
Similar companies · same sector, comparable size
Apotheek A. Meyers
BE 0416.590.056
Landen · Eq €222k
APOTHEEK VAN WAMBEKE
BE 0888.222.961
Oudenaarde · Eq €222k
Apothekers MARIABURG Ekeren
BE 0429.997.634
Antwerpen · Eq €222k
PHARMA GUILLAUME
BE 0656.563.207
Ciney · Eq €222k
TEMMERMAN
BE 0875.569.807
Gent · Eq €222k
Of 5,208 companies in sector 47730 we hold annual accounts for 3,850. 3,540 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-01-1989
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 37 filingsAddress and cadastre registers
Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.